Pierluigi Toniutto

prof.

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Pierluigi Toniutto is a faculty member at the Hepatology and Liver Transplantation Unit in Italy. His research focuses on hepatic encephalopathy, diabetes mellitus in liver transplant recipients, and primary biliary cholangitis management. He has published extensively on various topics, including risk factors associated with type 2 diabetes and treatment patterns in patients with hepatitis C virus infection. Professor Toniutto's work aims to enhance clinical outcomes for patients with liver diseases.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (13)

Paolo Caraceni

Full Professor of Internal Medicine

University of Bologna

ITALY

View details

Stefano Fagiuoli

full professor of Gastroenterology

University of Milano-Bicocca

ITALY

View details

Edmondo Falleti

ITALY

View details

Dario Saltini

University of Modena and Reggio Emilia

ITALY

View details

Francesco Curcio

University of Udine

ITALY

View details

Nicola Coppola

ITALY

View details

Maria Paola Anolli

University of Milan

ITALY

View details

Gaetano Bertino

Associate Professor of Gastroenterology

University of Catania

ITALY

View details

Alessandro Lupi

Direttore di struttura complessa - Head of Cardiology Dept

ITALY

View details

Roberta Gagliardi

University of Padua

ITALY

View details

Alberto Ferrarese

Padua University Hospital

ITALY

View details

Patrizio Pasqualetti

Associate Professor of Medical Statistics

Sapienza University of Rome

ITALY

View details

Luca Degli Esposti

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pierluigi Toniutto

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

A Real-World Analysis of the Population with Hepatitis C Virus Infection Affected by Type 2 Diabetes in Italy: Patients’ Characteristics, Comorbidity Profiles and Treatment Patterns

Sex differences in hepatic encephalopathy: addressing the knowledge gap

Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic Review

Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study

Modifiable and Non-Modifiable Risk Factors and Vascular Damage Progression in Type 2 Diabetes: A Primary Care Analysis

Perioperative administration of albumin in adult patients undergoing liver transplantation: A systematic review

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

Real-world experience with long-term albumin in patients with cirrhosis and ascites☆

The Equitable Benefit Approach to guide the assessment of medical and psychosocial factors in liver transplant candidacy

Trends in liver transplantation for primary sclerosing cholangitis

Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide

Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive review

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients

Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience

Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients

Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)

Vaccination against SARS‐CoV‐2 in liver transplant recipients: The game is still long and the outcome is uncertain

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience

Special Issue &ldquo;New Therapies of Liver Diseases&rdquo;

An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know

Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis

Collaborators (13)

Paolo Caraceni

Stefano Fagiuoli

Edmondo Falleti

Dario Saltini

Francesco Curcio

Nicola Coppola

Maria Paola Anolli

Gaetano Bertino

Alessandro Lupi

Roberta Gagliardi

Alberto Ferrarese

Patrizio Pasqualetti

Luca Degli Esposti

Make your next move.

Special Issue “New Therapies of Liver Diseases”